FDA Approves First Generic Versions Of Lamisil Tablets - Agency Also Approves Over-the-counter Terbinafine Cream To Treat Athlete's Foot

Main Category: Dermatology
Also Included In: Pharma Industry / Biotech Industry
Article Date: 13 Jul 2007 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  


Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The U.S. Food and Drug Administration recently approved the first generic versions of prescription Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis). Such infections occur when fungi invade a fingernail or toenail or the skin underneath the nail.

"This approval offers Americans additional alternatives when choosing medications to treat nail fungus infections," said Gary J. Buehler, R.Ph., director of FDA's Office of Generic Drugs.

FDA approved applications from multiple generic drug manufacturers for terbinafine hydrochloride tablets in 250-milligram formulations. Manufacturers include: Amneal Pharmaceuticals, Apotex Corp., Aurobindo Pharma USA Inc., Dr. Reddy's Laboratories Ltd., Gedeon Richter USA Inc., Genpharm Inc., Glenmark Pharmaceuticals Inc., InvaGen Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Orgenus Pharma Inc., Roxane Laboratories Inc., TEVA Pharmaceuticals USA, Watson Laboratories Inc., Wockhardt USA Inc.

The remaining patent or exclusivity for Lamisil expired on June 30, 2007.

According to the online trade magazine, Drug Topics, Lamisil tablets are the 57th highest selling brand-name prescription drug by retail dollars in the United States.

In addition to terbinafine tablets, FDA also approved an application for a generic version of over-the-counter Lamisil cream (terbinafine hydrochloride,1 percent) to treat athlete's foot, a skin disease caused by a fungus that usually occurs between the toes. The cream is manufactured by Taro Pharmaceuticals U.S.A. Inc.

The FDA's Office of Generic Drugs ensures that generic drugs are safe and effective through a thorough scientific and regulatory process.

Office of Generic Drugs

Generic Drugs: What You Need to Know

FDA monthly reports for first-time generics

http://www.fda.gov

View drug information on Lamisil Solution, 1%.


Article adapted by Medical News Today from original press release.
Visit our dermatology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
FDA. "FDA Approves First Generic Versions Of Lamisil Tablets - Agency Also Approves Over-the-counter Terbinafine Cream To Treat Athlete's Foot." Medical News Today. MediLexicon, Intl., 13 Jul. 2007. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/76685.php>

APA
FDA. (2007, July 13). "FDA Approves First Generic Versions Of Lamisil Tablets - Agency Also Approves Over-the-counter Terbinafine Cream To Treat Athlete's Foot." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/76685.php.

Please note: If no author information is provided, the source is cited instead.




Dermatology

Most Popular Articles



Follow Our Dermatology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Dermatology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »